REDX.L Share News (REDX)

Redx Pharma Makes Progress On Gonorrhoea Treatment And Other Drugs

Redx Pharma Continues Pipeline Progressing In Maiden Results

Earnings, Trading Statements Calendar - Week Ahead

New Redx director brings scientific, commercial expertise

(ShareCast News) - Redx announced the appointment of a non-executive director on Monday, with Dr Bernhard Kirschbaum joining the firm's board immediately. The AIM-listed self-described drug discovery and development company said Dr Kirschbaum was bringing with him more than 25 years experience in ph

Redx Pharma Identifies New Cancer Drug Development Candidate

Redx Pharma Says It Made "Good Progress" In Second Half

Redx Pharma And Horizon Discovery Collaborating On Cancer Research

Redx Pharma enjoys good progress during first-half

Two months after its admission to AIM, Redx Pharma said its first-half results were in line with expectations thanks to progress on potential MRSA drugs. Losses before tax rose 60.5% to £3.26m due to a decrease in grant funding and operating expenses increased 5% to £5.48m. The drug discovery and d

Redx Pharma Positive For Full Year, Loss Widens In Maiden Interims

Redx Pharma cheers with progress on potential MRSA drug

Redx shares jumped on the news it has reached the pre-clinical development stage with a new anti-infective compound designed to tackle MRSA, the bacteria that causes potentially lethal infections in humans. The pharmaceutical firm said the progress marked a "significant milestone" for its commercial

Redx Pharma Progresses To Pre-Clinical Stage With MRSA Treatment

Redx Pharma Identifies Second Drug Development Candidate

Redx Pharma To Launch New Immunology Subsidiary

Redx Pharma Says Third Paper On Antimicrobial Resistance Published